Features Lawrence Goldstein, PhD
Features Kelly Frazer, PhD, and Agnieszka D'Antonio-Chronowska, PhD
Cites research by Mark Tuszynski, MD, PhD
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need ...
Features Kelly Frazer, PhD, Erin Smith, PhD, and Agnieszka D'Antonio-Chronowska, PhD
Using stem cells derived from six people, UC San Diego School of Medicine researchers recapitulated retinal cells in the lab. This “eye-in-a-dish” model allowed them to identify genetic variants that ...
Features Dan Kaufman, MD, PhD
Features Sandip Patel, MD, and Dan Kaufman, MD, PhD
An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, ...
Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated wi ...
Features Sanford Stem Cell Clinical Center
Features Miles Wilkinson, PhD
Using a leading-edge technique, UC San Diego School of Medicine researchers defined the cell types in both newborn and adult human testes and identified biomarkers for spermatogonial stem cells, openi ...
Features Alysson Muotri, PhD
In a study published January 17, 2019 in Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation nega ...
Features Stephanie Cherqui, PhD
For the first time, researchers at University of California San Diego have used rapid 3D printing technologies to create a spinal cord, then successfully implanted that scaffolding, loaded with neural ...
UC San Diego researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Researchers at University of California San Diego School of Medicine describe development of a rapid, cost-effective method to create human cortical organoids directly from primary cells.
Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemothe ...
Thirteen years ago, Natalie made a wish that inspired her parents to found the Cystinosis Research Foundation. With their support, UC San Diego researchers are now developing a stem cell-based therapy ...
Time may blur, but the first quarter-century of the newly renamed Shiley Eye Institute – it celebrates that anniversary this year – remains sharply defined in its accomplishments and its focus on the ...
When UC San Diego Jacobs Medical Center opens in 2016, blood and marrow transplant patients will have rooms with panoramic views and leading-edge treatments such as stem cell-directed clinical transl ...